First human test of PRX019 drug shows no major red flags
NCT ID NCT06699680
First seen May 14, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This early-stage study tested the safety of a new drug called PRX019 in 50 healthy adults. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. The goal was to see if PRX019 is safe enough for further testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution
Los Alamitos, California, 90720, United States
Conditions
Explore the condition pages connected to this study.